文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

鉴定一个新的 PANoptosis 相关基因特征，用于预测透明细胞肾细胞癌的预后。

Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma.

机构信息

Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.

Department of Urology, Shanxian Central Hospital, Heze, Shandong, China.

出版信息

Medicine (Baltimore). 2024 Sep 27;103(39):e39874. doi: 10.1097/MD.0000000000039874.

DOI:10.1097/MD.0000000000039874
PMID:39331898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11441883/
Abstract

PANoptosis has been shown to play an important role in tumorigenesis and gain more attention. Yet, the prognostic significance of PANoptosis-related genes has not been investigated more in clear cell renal cell carcinoma (ccRCC). The aim of this research was designed to identify and create a signature of PANoptosis-related genes which was expected to predict prognosis of ccRCC more effectively. The transcriptome data and clinical information were collected from The Cancer Genome Atlas database and the Gene Expression Omnibus database. Optimal differentially expressed PANoptosis-related genes, which were closely associated with prognosis and employed to construct a risk score, were extracted by univariate Cox analysis, least absolute shrinkage and selection operator Cox regression and multivariate Cox analysis. We performed Kaplan-Meier survival analysis and time-dependent receiver operating characteristic curves to complete this process. By adopting univariate and multivariate analysis, the constructed risk score was assessed to verify whether it could be taken as an independent contributor for prognosis. Moreover, we created a nomogram in order to predict overall survival (OS) of ccRCC. Five differentially expressed PANoptosis-related genes were screened out and used to construct a risk score. Our results showed that ccRCC patients with high risk score had a poor prognosis and shorter OS. The results of Kaplan-Meier curves and the area under the receiver operating characteristic curves of 1-, 3-, and 5-year OS indicated that the prediction performance was satisfactory. Additionally, the risk model could be taken as an independent prognostic factor in training and validation cohorts. The nomogram exhibited excellent reliability in predicting OS, which was validated by calibration curves. We identified 5 PANoptosis-related genes, which were used to construct a risk score and a nomogram for prognostic prediction with reliable predictive capability. The present study may provide new potential therapeutic targets and precise treatment strategies for ccRCC.

摘要

细胞焦亡与肿瘤的发生发展密切相关，受到越来越多的关注。然而，细胞焦亡相关基因在透明细胞肾细胞癌（ccRCC）中的预后意义尚不清楚。本研究旨在鉴定和构建一个细胞焦亡相关基因特征，以期更有效地预测 ccRCC 的预后。从癌症基因组图谱（TCGA）数据库和基因表达综合数据库（GEO）中收集转录组数据和临床信息。通过单因素 Cox 分析、最小绝对收缩和选择算子 Cox 回归和多因素 Cox 分析，提取与预后密切相关并用于构建风险评分的最佳差异表达的细胞焦亡相关基因。我们进行 Kaplan-Meier 生存分析和时间依赖的受试者工作特征曲线来完成这个过程。通过采用单因素和多因素分析，评估构建的风险评分是否可以作为独立的预后因素。此外，我们创建了一个列线图，以预测 ccRCC 的总生存期（OS）。筛选出 5 个差异表达的细胞焦亡相关基因，用于构建风险评分。结果表明，风险评分高的 ccRCC 患者预后不良，OS 更短。Kaplan-Meier 曲线和 1、3、5 年 OS 的受试者工作特征曲线下面积的结果表明，预测性能令人满意。此外，该风险模型可作为训练和验证队列中独立的预后因素。列线图在预测 OS 方面表现出良好的可靠性，校准曲线也验证了这一点。我们确定了 5 个细胞焦亡相关基因，用于构建风险评分和列线图，以进行具有可靠预测能力的预后预测。本研究可能为 ccRCC 提供新的潜在治疗靶点和精确的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/854a6202d3c1/medi-103-e39874-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/7ec1712a5125/medi-103-e39874-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/711dc7a6695f/medi-103-e39874-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/54e988893f9d/medi-103-e39874-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/3be8360caf2d/medi-103-e39874-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/60994ec44a9e/medi-103-e39874-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/7df19efb8458/medi-103-e39874-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/cad81e724042/medi-103-e39874-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/b41db92f8f94/medi-103-e39874-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/34da1bd67607/medi-103-e39874-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/854a6202d3c1/medi-103-e39874-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/7ec1712a5125/medi-103-e39874-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/711dc7a6695f/medi-103-e39874-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/54e988893f9d/medi-103-e39874-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/3be8360caf2d/medi-103-e39874-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/60994ec44a9e/medi-103-e39874-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/7df19efb8458/medi-103-e39874-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/cad81e724042/medi-103-e39874-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/b41db92f8f94/medi-103-e39874-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/34da1bd67607/medi-103-e39874-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/854a6202d3c1/medi-103-e39874-g010.jpg

相似文献

[1]
Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma.

Medicine (Baltimore). 2024-9-27

[2]
A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.

BMC Cancer. 2021-4-9

[3]
Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients.

Medicine (Baltimore). 2021-10-1

[4]
Identification of a PANoptosis-related long noncoding rna risk signature for prognosis and immunology in colon adenocarcinoma.

BMC Cancer. 2025-4-10

[5]
Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma.

Med Sci Monit. 2020-12-9

[6]
Transcriptome analysis revealed a novel nine-gene prognostic risk score of clear cell renal cell carcinoma.

Medicine (Baltimore). 2024-9-27

[7]
Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.

Biosci Rep. 2020-9-30

[8]
Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.

Ann Clin Lab Sci. 2021-9

[9]
Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma.

Aging (Albany NY). 2021-1-10

[10]
Construction and validation of a survival prognostic model for clear cell renal cell carcinoma.

Clin Nephrol. 2025-3

本文引用的文献

[1]
The Role of MUC1 in Renal Cell Carcinoma.

Biomolecules. 2024-3-7

[2]
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma.

Int J Mol Sci. 2023-11-20

[3]
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers.

Int J Mol Sci. 2023-8-24

[4]
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma.

J Clin Med. 2023-6-7

[5]
Mitochondrial dysfunctions induce PANoptosis and ferroptosis in cerebral ischemia/reperfusion injury: from pathology to therapeutic potential.

Front Cell Neurosci. 2023-5-24

[6]
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice.

Biomedicines. 2023-4-2

[7]
PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis.

J Inflamm Res. 2023-4-12

[8]
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery.

Expert Rev Mol Diagn. 2023-4

[9]
Molecular subtypes based on PANoptosis-related genes and tumor microenvironment infiltration characteristics in lower-grade glioma.

Funct Integr Genomics. 2023-3-17

[10]
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation.

Int J Mol Sci. 2023-3-2

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索